Pancreatic Cancer Screening for At-risk Individuals

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Beth Israel Deaconess Medical Center
Study ID
NCT05006131
Status
Recruiting
Apply to this trial

Conditions

  • Pancreatic Cancer, Adult

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Screening for pancreatic cancer — OTHER
    Screening for pancreatic cancer using EUS or MRI

Study Details

The investigators' goal is to conduct a prospective multicenter study to evaluate the yield and outcomes of screening of pancreas cancer in individuals who are at-risk for pancreatic cancer. We plan to use International Cancer of the Pancreas Screening (CAPS3) Consortium recommendations to standardize study population, screening methodology, and study outcomes.

Key Dates

Start date
Jul 10, 2020
Status verified
Apr 2026
Primary completion
Dec 31, 2032
Completion
Dec 31, 2032

Study Design

Enrollment
1,395 participants (estimated)

Arms

  • Arm: Patients who are at high-risk for pancreatic cancer
    Patients that meet the eligibility criteria based on CAPS3 or updated national pancreatic cancer screening guidelines

Primary Outcome Measure

Proportion of screening patients found to have high-risk pancreatic lesions amenable to treatment [ Time Frame: From year 1 to year 12 (until the end of at least 5 years follow up in 2032), according to the standard of care designated by GI team. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Roya Dastjerdi, MPH
[email protected]
617 667 4046
Mandeep Sawhney, MD,MS,FASGE (PRINCIPAL_INVESTIGATOR)
Andy Silva-Santisteban, MD (SUB_INVESTIGATOR)

Find similar trials in Boston, MA

By research site
Beth Israel Deaconess Medical Center· Boston, MA

Related Studies